Abstract

Blood culture contamination (BCC) is a significant problem in the emergency department (ED) setting. False positive blood culture results are associated with unnecessary treatment and increased costs. Many patients with false positive cultures receive empiric broad-spectrum antibiotics, putting them at risk for complications such as Clostridium difficile and acute kidney injury, as well as further diagnostic workup. Additional treatment results in longer hospital stays and increased risk of hospital-acquired infections including multi-drug-resistant organisms (MDROs). In an effort to reduce the number of false positive blood cultures in our ED, we initiated a trial of a novel device for blood sample collection. The Initial Specimen Diversion Device (ISDD)(Steripath, Magnolia Medical Technologies) has been shown to reduce contamination by diverting and isolating the initial 1.5-2.0 mL of blood(most likely to contain skin fragments and bacteria) from the remaining sample. Our ED implemented this device into our regular blood culture protocol and tracked the results, with the goal of reducing our BCC rate to below 1.5%.

Authors

Kara Bauman

Author Details

Kara Bauman, MN, RN, CEN, CPEN, TCRN

Sigma Membership

Non-member

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Quality Care, Intravenous, Blood Culture Contaminations

Conference Name

Emergency Nursing 2019

Conference Host

Emergency Nurses Association

Conference Location

Austin, Texas, USA

Conference Year

2019

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

Abstract Review Only: Reviewed by Event Host

Acquisition

Proxy-submission

Poster

Additional Files

Abstract.pdf (100 kB)

Share

COinS
 

Don't stick me again! Reducing blood culture contaminations

Austin, Texas, USA

Blood culture contamination (BCC) is a significant problem in the emergency department (ED) setting. False positive blood culture results are associated with unnecessary treatment and increased costs. Many patients with false positive cultures receive empiric broad-spectrum antibiotics, putting them at risk for complications such as Clostridium difficile and acute kidney injury, as well as further diagnostic workup. Additional treatment results in longer hospital stays and increased risk of hospital-acquired infections including multi-drug-resistant organisms (MDROs). In an effort to reduce the number of false positive blood cultures in our ED, we initiated a trial of a novel device for blood sample collection. The Initial Specimen Diversion Device (ISDD)(Steripath, Magnolia Medical Technologies) has been shown to reduce contamination by diverting and isolating the initial 1.5-2.0 mL of blood(most likely to contain skin fragments and bacteria) from the remaining sample. Our ED implemented this device into our regular blood culture protocol and tracked the results, with the goal of reducing our BCC rate to below 1.5%.